Docoh
Loading...

NTLA Intellia Therapeutics

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

ESG term mentions

In last year of SEC filings

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
Intellia Therapeutics, Inc. (the “Company”) held its Annual Meeting of Stockholders on June 23, 2021 (the “Annual Meeting”). The following is a summary of the matters voted on at that meeting.

a)The stockholders of the Company elected Fred Cohen, M.D., D.Phil., Jean-François Formela, M.D. and Frank Verwiel, M.D. as class II directors, for a three-year term ending at the annual meeting of stockholders to be held in 2024 and until his successor has been duly elected and qualified or until his earlier resignation or removal. The results of the stockholders’ vote with respect to the election of the class II directors were as follows:


NameVotes

For
Votes

Withheld
Broker

Non-Votes
Fred Cohen, M.D., D.Phil. 41,255,40611,687,5946,873,739
Jean-François Formela, M.D. 40,022,51312,920,4876,873,739
Frank Verwiel, M.D.32,835,93420,107,0666,873,739


b)The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the stockholders’ vote with respect to such ratification were as follows:


Votes

For
Votes

Against
AbstainBroker Non-Votes
59,754,33828,40733,9940


c)The stockholders of the Company approved, on an advisory basis, the compensation of the named executive officers. The results of the stockholders’ vote with respect to the approval of the compensation of the named executive officers were as follows:


Votes

For
Votes

Against
AbstainBroker Non-Votes
51,721,7801,157,07464,1466,873,739


No other matters were submitted to or voted on by the Company’s stockholders at the Annual Meeting.